Literature DB >> 33609159

Antibodies to MOG in CSF only: pathological findings support the diagnostic value.

Sara Carta1, Romana Höftberger2, Anna Bolzan1, Silvia Bozzetti1, Bruno Bonetti3, Mauro Scarpelli3, Sarah Ottaviani3, Claudio Ghimenton4, Daniela Alberti1, Kathrin Schanda5, Markus Reindl5, Romain Marignier6, Sergio Ferrari1, Sara Mariotto7.   

Abstract

Entities:  

Year:  2021        PMID: 33609159     DOI: 10.1007/s00401-021-02286-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  4 in total

1.  Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases.

Authors:  Sara Mariotto; Alberto Gajofatto; Lucia Batzu; Rachele Delogu; GianPietro Sechi; Stefania Leoni; Maria Immacolata Pirastru; Bruno Bonetti; Mattia Zanoni; Daniela Alberti; Kathrin Schanda; Salvatore Monaco; Markus Reindl; Sergio Ferrari
Journal:  Neurology       Date:  2019-10-23       Impact factor: 9.910

2.  Unilateral Leptomeningeal Enhancement in Myelin Oligodendrocyte Glycoprotein Immunoglobulin G-Associated Disease.

Authors:  Adrian Budhram; Amy C Kunchok; Eoin P Flanagan
Journal:  JAMA Neurol       Date:  2020-05-01       Impact factor: 18.302

3.  Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.

Authors:  Yoshiki Takai; Tatsuro Misu; Kimihiko Kaneko; Norio Chihara; Koichi Narikawa; Satoko Tsuchida; Hiroya Nishida; Takashi Komori; Morinobu Seki; Teppei Komatsu; Kiyotaka Nakamagoe; Toshimasa Ikeda; Mari Yoshida; Toshiyuki Takahashi; Hirohiko Ono; Shuhei Nishiyama; Hiroshi Kuroda; Ichiro Nakashima; Hiroyoshi Suzuki; Monika Bradl; Hans Lassmann; Kazuo Fujihara; Masashi Aoki
Journal:  Brain       Date:  2020-05-01       Impact factor: 13.501

4.  Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology.

Authors:  Franziska Di Pauli; Romana Höftberger; Markus Reindl; Ronny Beer; Paul Rhomberg; Kathrin Schanda; Douglas Sato; Kazuo Fujihara; Hans Lassmann; Erich Schmutzhard; Thomas Berger
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-11-04
  4 in total
  4 in total

Review 1.  Pathogenic autoantibodies in multiple sclerosis - from a simple idea to a complex concept.

Authors:  Romana Höftberger; Hans Lassmann; Thomas Berger; Markus Reindl
Journal:  Nat Rev Neurol       Date:  2022-08-15       Impact factor: 44.711

Review 2.  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management.

Authors:  Elia Sechi; Laura Cacciaguerra; John J Chen; Sara Mariotto; Giulia Fadda; Alessandro Dinoto; A Sebastian Lopez-Chiriboga; Sean J Pittock; Eoin P Flanagan
Journal:  Front Neurol       Date:  2022-06-17       Impact factor: 4.086

Review 3.  Testing for Antibodies Against Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in the Diagnosis of Patients With Suspected Autoimmune Myelopathy.

Authors:  Samir Alkabie; Adrian Budhram
Journal:  Front Neurol       Date:  2022-05-20       Impact factor: 4.086

Review 4.  Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease.

Authors:  Alessandro Dinoto; Elia Sechi; Eoin P Flanagan; Sergio Ferrari; Paolo Solla; Sara Mariotto; John J Chen
Journal:  Front Neurol       Date:  2022-03-23       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.